Abbott launches over-the-counter continuous glucose monitor in the US

(Reuters) -Abbott has launched its over-the-counter continuous glucose monitoring system Lingo in the United States, the company said on Thursday.

Lingo is available for consumers 18 years and older not on insulin in three payment options – $49 for two weeks, $89 for four weeks and $249 for 12 weeks.

Abbott received FDA clearance for Lingo in June.

(Reporting by Sneha S K; Editing by Janane Venkatraman)